Genetic risk determines the emergence of diabetes-associated autoantibodies in young children

Diabetes

Volumn 51, Issue 3, 2002, Pages 646-651

  Kupila, Antti ^a   Keskinen, Päivi ^c   Simell, Tuula ^a   Erkkilä, Satu ^a   Arvilommi, Paula ^a   Korhonen, Sari ^b   Kimpimäki, Teija ^c   Sjöroos, Minna ^a   Ronkainen, Matti ^b   Ilonen, Jorma ^a   Knip, Mikael ^d   Simell, Olli ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ ANTIGEN; IA ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FOLLOW UP; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION;

EID: 0036313575     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.646     Document Type: Article

References (27)

1. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
2. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
3. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives
4. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: A population-based study: The Childhood Diabetes in Finland Study Group
5. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children
6. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with type I diabetes: The German BABY- DIAB study
7. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives
8. Islet autoimmunity in infants with a type I diabetic relative is common but is frequently restricted to one autoantibody
9. Prevention of type 1 diabetes. Is now the time?
10. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus: The Childhood Diabetes in Finland (DiMe) Study Group
11. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: Diabetes Autoimmunity Study in the Young (DAISY)
12. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort
13. Population based genetic screening for type 1 diabetes mellitus risk in Finland: Selective genotyping of the markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci
14. Triple-label hybridization assay for type-1 diabetes-related HLA alleles
15. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population: The Childhood Diabetes in Finland (DiMe) Study Group
16. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
17. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease
18. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies: The Immunology and Diabetes Workshops and Participating Laboratories
19. Autoanti-bodies associated with type I diabetes mellitus persist after diagnosis in children
20. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
21. IA-2 antibodies - A sensitive marker of IDDM with clinical onset in childhood and adolescence
22. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies
23. A novel micro-assay for insulin autoantibodies
24. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
25. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
26. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
27. Karlsburg type I diabetes risk study of a general population: Frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren